Navigation Links
Sarah Cannon Research Institute Selects OmniComm Systems' Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
Date:11/4/2008

Renowned cancer research center enters into a Technology Transition agreement with OmniComm to gain more control over the management of their

clinical trials

FT. LAUDERDALE, Fla., Nov. 4 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated EDC solutions for clinical trials, today announced that after an extensive evaluation of the leading EDC vendors, the Sarah Cannon Research Institute (SCRI), http://www.sarahcannonresearch.com , has chosen to use OmniComm's TrialMaster for their electronic data capture software and services needs. SCRI selected OmniComm for several key reasons, including TrialMaster's functionality. However, the deciding factor was OmniComm's responsiveness and the level of service that the company delivers, something that SCRI requires for their sites.

"Our partnership with OmniComm provides us with site service and support as well as the easy use of their EDC, which allows us to scale our business to meet the demands of our customers," said Phil Cestaro, CFO/CIO of SCRI.

SCRI is one of the largest clinical research programs in the nation, conducting community-based clinical trials in oncology and other therapeutic areas through affiliations with a network of nearly 500 physicians in 24 states. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites across the country.

"OmniComm's experience in working with world class oncology research centers gives us great satisfaction as a company to know that our cutting edge software is helping to bring novel drugs and therapies to market sooner," said Stephen Johnson, COO of OmniComm. Ken Light, Sr. Vice President of Professional Services for OmniComm added, "Our implementation team stands ready to provide the superior support services needed to effectively transition the use of EDC in-house at the Sarah Cannon Research Center. We are honored to be working with SCRI."

About OmniComm

OmniComm Systems, Inc. ( http://www.OmniComm.com ) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarah Palin, Dr. Siegals Cookie Diet, and John McCain Top AOL Hot Searches List on August 29th
2. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
3. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
4. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
5. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
6. Alzheimers Association Grant Furthers Successful Research at UMass Lowell
7. Local Research Foundation Achieves Milestone in Fight Against Cancer
8. Congresswoman Supporting Spinal Cord Research Intended to Benefit U.S. Veterans
9. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
10. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
11. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):